婴儿SARS-CoV-2和RSV感染之间的临床差异:病例对照研究的发现
Victor Daniel Miron1, Raluca-Oana Raianu1, Claudiu Filimon1
1Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Viruses
|January 23, 2024
概括
患有COVID-19的婴儿通常会出现发烧和腹,而RSV感染的婴儿通常会导致咳和呼吸障碍等呼吸系统症状. 在婴儿中区分这些病毒感染需要进行诊断测试以进行适当的管理.
科学领域:
- 儿童传染病 儿童传染病
- 病毒学 病毒学
- 流行病学 流行病学
背景情况:
- 婴儿面临着高的住院率和急性感染的严重后果.
- 在婴儿中区分SARS-CoV-2 (COVID-19) 和呼吸道同胞病毒 (RSV) 对于有效的临床管理至关重要.
- 了解这些病毒在婴儿中的不同临床表现和后果是必不可少的.
研究的目的:
- 为了比较患有SARS-CoV-2和RSV感染的住院婴儿的临床特征,实验室发现和结果.
- 为了确定COVID-19和RSV在儿科人口中的症状和并发症的关键差异.
- 为了告知婴儿这些病毒感染的诊断和管理策略.
主要方法:
- 进行了一项追溯病例控制研究,涉及188名婴儿 (94名患有SARS-CoV-2,94名患有RSV) 在一年内住院.
- 收集的数据包括临床症状,实验室结果 (如淋巴细胞计数) 和住院时间.
- 使用统计分析来比较两个组之间的结果.
主要成果:
- 患有COVID-19的婴儿更有可能发烧 (10.2倍) 和腹 (2.4倍).
- 患有RSV的婴儿咳 (2.5倍),鼻塞 (3.0倍) 和呼吸障碍 (14.7倍) 的比率更高.
- RSV与呼吸系统衰竭 (27.3倍) 的风险增加有关,而COVID-19增加了喉炎 (5.8倍) 的风险.
结论:
- 婴儿的SARS-CoV-2通常伴有发烧,而RSV通常表现为呼吸系统症状.
- 实验室差异化可能具有挑战性,这强调了快速诊断测试的必要性.
- 有针对性的监测和控制措施对于减轻这些病毒对婴儿的影响至关重要.
更多相关视频
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
7.9K
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
10.9K
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Pneumonia II: Pathophysiology
278
The pathophysiology of pneumonia involves the following steps:
278
Acute Respiratory Failure-II
238
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
238
Acute Respiratory Failure-I
212
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
212
Acute Respiratory Failure-V
141
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
141
